argenx is a biotechnology company committed to improving the lives of patients through immunology innovation. The company focuses on developing novel antibody-based therapies to treat severe autoimmune diseases. Using a collaborative approach with pioneering scientists and academic partners, argenx accelerates the discovery of therapeutic antibodies that target specific disease pathways. The company's proprietary products, such as efgartigimod, are aimed at treating diseases where IgG antibodies are pathogenic. Argenx emphasizes innovation, science of collaboration, and patient-centric approaches in its mission to deliver life-changing medical solutions.
Oncology β’ Autoimmune diseases β’ Rare Diseases β’ Antibody based medicines β’ Immunotherapy
March 13
Manage clinical development plans and teams within a global immunology biotech firm.
February 14
Lead pricing and reimbursement strategies for argenx's innovative therapies in a global context.
February 12
Lead regulatory guidance for promotional communications related to argenx's commercial products.
February 7
Research Fellow role involves antibody-based therapeutic studies at the Centre for Cancer Immunology. Join a team dedicated to healthcare innovation and scientific advancement.
October 22, 2024
Lead patient advocacy and public policy for argenx's German team.